Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Bimosiamose

Generic Name: Bimosiamose

Drug Type: Small Molecule

Chemical Formula: C_₄₆H_₅₄O_₁₆

CAS Number: 187269-40-5

Unique Ingredient Identifier: 97B5KCW80W

Overview

No overview information available.

Background

No background information available.

Indication

Investigated for use/treatment in asthma, psoriasis and psoriatic disorders, atopic dermatitis, inflammatory disorders (unspecified), and chronic obstructive pulmonary disease (COPD).

Associated Conditions

No associated conditions information available.

Clinical Trials

Study to Evaluate Safety and Efficacy of Inhaled Bimosiamose for the Treatment of Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Phase 2

Completed

Posted: 2010/04/22

Sponsor:Revotar Biopharmaceu...

ID:NCT01108913

Study to Evaluate the Effect of Bimosiamose on Ozone Induced Sputum Neutrophilia

Phase 2

Completed

Posted: 2009/08/20

Sponsor:Revotar Biopharmaceu...

ID:NCT00962481

Safety and Efficacy Study of Bimosiamose Cream to Treat Psoriasis

Phase 2

Completed

Posted: 2009/01/16

Sponsor:Revotar Biopharmaceu...

ID:NCT00823693

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy